Afinum has formed MedTech Laser Group, an integrated medical laser technologies provider, through the acquisition of ARC Laser and NeoLaser. ARC Laser is a medical laser technology development platform. It provides laser technologies focused on ophthalmic treatments, particularly for glaucoma and cataract procedures. It has diversified its product portfolio to include surgical applications e.g. in laryngology, otology, rhinology, as well as veterinary medicine. Tel Aviv-based NeoLaser is a specialist in laser systems and fibres for endovenous laser ablation and applications in proctology. The global market for ophthalmologic and surgical lasers is poised for substantial growth, driven by various secular trends such as aging population, increasing prevalence of relevant diseases and technological advancements in laser treatments driving adoption across medical disciplines, according to a release. The companies will lever their combined strengths to collaborate on research and development, sales and marketing, as well as regulatory matters. The joint growth strategy will emphasise international expansion, an enhanced go to market approach and further driving organisational development, the release said. The group will broaden its technology and product portfolio organically and potentially through strategic add-on acquisitions. This transaction is the tenth platform investment via Afinum 9 fund and the second thematic investment in the MedTech sector.

Afinum in second medtech deal with MedTech Laser Group

Afinum has formed MedTech Laser Group through the acquisition of ARC Laser and NeoLaser, aiming to become an integrated medical laser technologies provider. The group will focus on ophthalmic treatments, surgical applications, and international expansion.